We are live on
!
Find out more
EAM
Erste Asset Management Portfolio holdings
AUM
$12.9B
1-Year Est. Return
52.69%
This Fund
S&P 500
This Quarter
Est. Return
-16.19%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$1.49B
AUM Growth
–
Cap. Flow
+$1.64B
Cap. Flow
% of AUM
110.29%
Top 10 Holdings %
Top 10 Hldgs %
25.03%
Holding
443
New
443
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$63.6M |
| 2 |
Microsoft
MSFT
|
+$62.3M |
| 3 |
CELG
Celgene Corp
CELG
|
+$52.1M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$37.9M |
| 5 |
Agios Pharmaceuticals
AGIO
|
+$34.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.3% |
| 2 | Technology | 21.29% |
| 3 | Consumer Discretionary | 12.85% |
| 4 | Financials | 8.82% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.35T
| $58.6M | 3.94% |
+581,486
| New | +$62.3M |
|
|
2
Sarepta Therapeutics
SRPT
$1.64B
| $54.8M | 3.69% |
+508,810
| New | +$63.6M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $44.2M | 2.97% |
+706,410
| New | +$52.1M |
|
|
4
Vertex Pharmaceuticals
VRTX
$122B
| $35.4M | 2.38% |
+218,700
| New | +$37.9M |
|
5
Starbucks
SBUX
$121B
| $33.5M | 2.25% |
+528,730
| New | +$33.1M |
|
6
Meta Platforms (Facebook)
META
$1.37T
| $31.5M | 2.12% |
+235,960
| New | +$34.2M |
|
7
Texas Roadhouse
TXRH
$13.7B
| $30.9M | 2.07% |
+521,055
| New | +$33.5M |
|
8
BioMarin Pharmaceuticals
BMRN
$11.7B
| $29.4M | 1.98% |
+351,840
| New | +$33.5M |
|
9
Bristol-Myers Squibb
BMY
$132B
| $28.8M | 1.93% |
+565,370
| New | +$30.4M |
|
|
10
Agios Pharmaceuticals
AGIO
$1.95B
| $25.3M | 1.7% |
+559,600
| New | +$34.5M |
|
|
TIF
11
DELISTED
Tiffany & Co.
TIF
| $24.8M | 1.67% |
+313,650
| New | +$32M |
|
12
Sabre
SABR
$739M
| $23.6M | 1.59% |
+1,100,000
| New | +$26.6M |
|
13
Qualcomm
QCOM
$160B
| $23.3M | 1.57% |
+410,000
| New | +$24.9M |
|
14
Bath & Body Works
BBWI
$4.02B
| $22.9M | 1.54% |
+1,113,300
| New | +$28.1M |
|
15
Silicon Motion
SIMO
$8.65B
| $22.3M | 1.5% |
+642,780
| New | +$25.1M |
|
16
Tapestry
TPR
$30.8B
| $22M | 1.48% |
+650,000
| New | +$26.2M |
|
17
ON Semiconductor
ON
$32.6B
| $21.2M | 1.43% |
+1,300,000
| New | +$22.5M |
|
18
Alphabet (Google) Class A
GOOGL
$4.08T
| $20.9M | 1.4% |
+396,660
| New | +$21.4M |
|
19
LKQ Corp
LKQ
$5.76B
| $20.4M | 1.37% |
+850,000
| New | +$23.1M |
|
20
Visa
V
$673B
| $15.7M | 1.06% |
+119,425
| New | +$16.5M |
|
21
Apple
AAPL
$4.9T
| $15.1M | 1.01% |
+386,092
| New | +$18.7M |
|
22
Adobe
ADBE
$98.5B
| $14.5M | 0.97% |
+64,471
| New | +$15.6M |
|
23
Biogen
BIIB
$30.7B
| $14.2M | 0.95% |
+48,087
| New | +$15.3M |
|
24
Amgen
AMGN
$209B
| $14.1M | 0.95% |
+74,155
| New | +$14.5M |
|
25
Illumina
ILMN
$31B
| $13.5M | 0.91% |
+46,363
| New | +$14.4M |
|
Similar funds
AIM
TRSOTSOK
GC
CII
AAMU
NMIFOAC
WANY
Erste Asset Management's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Erste Asset Management, which disclosed 443 positions worth $1.49B. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Sarepta Therapeutics: 508,810 shares worth $54.8M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, followed by Technology and Consumer Discretionary.
- Erste Asset Management's largest Q4 2018 buy was Sarepta Therapeutics: 508,810 shares worth $54.8M.
- Erste Asset Management's ten largest holdings make up 25% of its $1.49B portfolio in Q4 2018.
- Erste Asset Management disclosed 443 positions in Q4 2018, its first 13F filing on record.
Based on Erste Asset Management's 13F filing for Q4 2018, filed 26 Nov 2024.